tRNA m7G Modification Sequencing enables site-resolved analysis of internal N7-methylguanosine (m7G) across the tRNA transcriptome. In many cytosolic tRNAs, m7G is commonly located at position 46 within the variable loop and is associated with the METTL1/WDR4 methyltransferase system. Because tRNA modification patterns can influence RNA structure, stability, and translation-related processes, reliable m7G mapping is valuable for studying modification pathways, perturbation responses, and tRNA-dependent regulation.
Our tRNA m7G modification sequencing services combine chemistry-based m7G detection, tRNA-focused library preparation, high-throughput sequencing, and bioinformatics analysis. Depending on the research objective, TRAC-Seq, quantitative m7G sequencing strategies, enrichment-based approaches, or integrated tRNA analysis can be selected to support site discovery, comparative profiling, and modification-focused research.
Fig 1. Positions of the m7G modification in tRNA. (Tomikawa C, 2018)
Locating m7G at Individual tRNA Sites: Global methylation measurements can indicate that m7G is present but cannot determine which tRNAs carry the modification or where the modified nucleotide occurs. Chemistry-based sequencing approaches can convert m7G reactivity into position-specific sequencing signals, supporting nucleotide-level mapping across suitable tRNA species.
Working With Highly Modified tRNA: tRNAs are compact, strongly structured, and densely modified. Several naturally occurring RNA modifications interfere with reverse transcription, which can reduce coverage and distort sequencing results. tRNA-focused pretreatment and library strategies help reduce these barriers before sequencing.
Separating Modification Changes From tRNA Abundance: A stronger or weaker sequencing signal may reflect altered methylation, altered tRNA abundance, or both. Comparative studies therefore benefit from experimental designs that evaluate m7G signals together with tRNA coverage and complementary tRNA expression information when appropriate.
Resolving Closely Related tRNAs: tRNA genes frequently contain highly similar isoacceptor and isodecoder sequences, creating multi-mapping challenges in short-read datasets. tRNA-aware reference construction, alignment rules, and reporting at the appropriate annotation level are important for avoiding overinterpretation of ambiguous reads.
Choosing the Right m7G Readout: Projects focused on site discovery, relative modification changes, or modification stoichiometry do not necessarily require the same assay. We help determine whether TRAC-Seq, quantitative m7G sequencing, enrichment-based profiling, or integration with broader tRNA modification analysis best matches the research question.
Our service framework supports projects ranging from global tRNA m7G site discovery to condition-dependent modification analysis. Experimental chemistry, sequencing strategy, controls, and bioinformatics are planned together so that the resulting dataset addresses the intended modification question rather than simply generating small-RNA sequencing reads.
Available approaches can include TRAC-Seq, quantitative m7G sequencing, enrichment-based m7G analysis, comparative experimental designs, and integration with complementary tRNA datasets.
Fig 2. The formation of m7G modification. (Tomikawa C, 2018)
Different m7G methods answer different experimental questions. TRAC-Seq is particularly suited to nucleotide-resolution tRNA m7G mapping, while quantitative chemical sequencing approaches can support estimation of modification changes at defined sites. Enrichment-based methods are more appropriate when broader m7G-associated RNA profiling is required.
| Method | Primary Readout | Typical Resolution | Key Consideration | Best-Fit Research Question |
| TRAC-Seq | m7G-dependent cleavage signals across tRNAs | Single nucleotide | Requires controlled chemical processing and tRNA-focused library preparation | Where are m7G sites located across the tRNA transcriptome? |
| Quantitative m7G Sequencing | Reverse-transcription signatures generated after chemical conversion | Single nucleotide with quantitative potential | Quantitative interpretation depends on workflow design, sequence context, coverage, and controls | How does internal m7G modification change at defined sites? |
| m7G Enrichment Sequencing | Enrichment of m7G-associated RNA regions | Enrichment region | Does not provide the same positional precision as dedicated chemical mapping | Which RNAs or regions show differential m7G enrichment? |
| Standard tRNA-Seq | tRNA abundance and selected modification-associated reverse-transcription signatures | tRNA family to sequence-dependent site information | Not a dedicated m7G mapping method | Are m7G-associated changes accompanied by altered tRNA abundance? |
| Broader Modification Analysis | Multiple tRNA modification classes using fit-for-purpose analytical approaches | Method dependent | Requires method selection according to the chemistry of each modification | Is m7G part of wider remodeling of the tRNA modification landscape? |
A useful m7G sequencing dataset requires more than a list of mapped reads. Analysis should connect sequencing quality, tRNA assignment, modification-specific signals, group comparisons, and biological annotation while clearly identifying positions where sequence similarity limits isodecoder-level interpretation.
| Analysis Module | Question Addressed | Typical Output | Interpretation Point | Applicable Workflow |
| Sequencing QC | Is the library suitable for reliable downstream analysis? | Read-quality metrics, adapter statistics, library complexity, and usable-read summaries | Low-complexity or strongly biased libraries may limit modification calling | All workflows |
| tRNA Mapping | Which tRNA families and sequences are represented? | Mapping statistics, coverage profiles, and isoacceptor or resolvable isodecoder assignments | Highly homologous tRNAs may require grouped reporting | TRAC-Seq / Quantitative m7G Sequencing |
| m7G Site Calling | Which positions show modification-specific sequencing evidence? | Site tables containing tRNA annotation, nucleotide position, coverage, and modification signal | Signal thresholds should be interpreted together with coverage and appropriate controls | TRAC-Seq / Quantitative m7G Sequencing |
| Cleavage Analysis | How strong is the TRAC-Seq signal at each candidate m7G position? | Position-specific cleavage scores and read-start distributions | Cleavage scores are chemistry-derived sequencing metrics and should not automatically be interpreted as absolute methylation fractions | TRAC-Seq |
| Quantitative Analysis | How does the modification level vary at defined internal sites? | Mutation spectra, deletion rates, and method-supported modification estimates | Sequence context and reverse-transcription behavior can influence quantitative signatures | Quantitative m7G Sequencing |
| Differential m7G | Which sites differ between experimental groups? | Differential tables, change summaries, clustering, and comparative visualizations | Modification changes should be reviewed alongside tRNA coverage and abundance | Comparative studies |
| Sequence Context | Are detected sites associated with recurring sequence or positional patterns? | Motif summaries and local sequence-context annotation | Sequence association supports interpretation but does not replace experimental modification evidence | TRAC-Seq / Quantitative m7G Sequencing |
| Integrated Analysis | How are m7G changes related to tRNA abundance or fragmentation? | Cross-dataset comparisons and prioritized tRNA candidates | Integration works best with matched experimental groups and compatible annotation strategies | Multi-assay projects |
The workflow is adapted to the selected m7G detection method, sample type, organism, and research objective. For TRAC-Seq projects, the workflow uses controlled chemical processing to convert m7G into sequencing-detectable cleavage signals for downstream site-level analysis.
We review the organism, sample type, experimental groups, biological question, available RNA, and desired readout. The project is then aligned with TRAC-Seq, quantitative m7G sequencing, enrichment-based analysis, or an integrated tRNA strategy so that sequencing resolution matches the intended research objective.
RNA quantity, integrity, and sample handling information are reviewed before processing. Small-RNA or tRNA-focused preparation is performed as required by the workflow because degradation or loss of the short-RNA fraction can directly reduce usable tRNA coverage.
For TRAC-Seq, pretreatment is used to reduce selected reverse-transcription-interfering modification effects while preserving the m7G signal required for downstream chemistry. This improves accessibility of heavily modified tRNA molecules and supports more interpretable sequencing libraries.
TRAC-Seq uses controlled chemical reduction followed by cleavage chemistry to generate RNA termini associated with m7G-containing positions. Quantitative workflows can instead convert m7G into reverse-transcription-detectable signatures suitable for site-level comparative analysis.
Chemistry-derived RNA products are converted into sequencing libraries using method-appropriate adapter ligation, reverse transcription, amplification, and quality assessment. Libraries meeting the agreed quality criteria are advanced to high-throughput sequencing.
Sequencing reads are processed through a tRNA-aware bioinformatics workflow for mapping, site detection, modification-signal calculation, comparative analysis, and annotation. Deliverables can include raw data, processed tables, quality-control summaries, figures, and interpretation-ready result files.
tRNA m7G analysis combines specialized RNA chemistry with sequencing and tRNA-specific computational challenges. Our workflow is designed around these constraints so that customers can select an assay based on the required biological readout rather than treating every m7G project as a conventional RNA-seq experiment.
Site-resolved tRNA m7G analysis can support mechanistic research into modification enzymes, tRNA stability, translation, stress responses, RNA processing, and coordinated changes within the tRNA epitranscriptome. The most informative study design depends on whether m7G is being examined as a primary molecular event or as one component of a broader tRNA phenotype.
A successful tRNA m7G project starts with a clear definition of the required readout. Whether your objective is nucleotide-level TRAC-Seq mapping, quantitative internal m7G analysis, comparative profiling, or integration with broader tRNA datasets, our team can help align sample preparation, chemistry, sequencing, and bioinformatics with the research question. Providing the organism, sample type, number of experimental groups, approximate sample availability, and whether the primary goal is site discovery or quantitative comparison can help streamline technical assessment. Contact us to discuss your tRNA m7G modification sequencing project.
We employ three complementary methods: MeRIP-Seq for antibody-based enrichment, TRAC-Seq for chemical reduction mapping, and m7G-Quant-Seq for quantitative analysis at single-base resolution.
m7G modifications influence tRNA structural stability, translation efficiency, and thermal stability, providing insights into translational regulation mechanisms in various biological systems.
TRAC-Seq combines AlkB demethylation with specific chemical reduction to achieve unbiased, nucleotide-resolution mapping of m7G sites across the tRNA transcriptome.
High-quality tRNA samples with minimal degradation are essential. We recommend providing purified tRNA with documentation of extraction methods and quality control metrics.
Our service includes comprehensive data analysis covering site identification, modification quantification, differential analysis, and functional annotation of detected m7G sites.
Yes, our analytical pipeline enables comparative analysis of m7G profiles between sample groups, identifying differentially modified sites and their potential functional implications.
Loading ......
